02/14/2024 7:31 PM | Cellectar Biosciences (Subject) Rosalind Advisors, Inc. (Filed by)
| Form SC 13G/A | |
02/14/2024 2:23 PM | Cellectar Biosciences (Subject) LYTTON LAURENCE W (Filed by)
| Form SC 13G/A | |
02/07/2024 5:58 PM | Cellectar Biosciences (Subject) HIRSCHMAN ORIN (Filed by)
| Form SC 13G/A | |
02/02/2024 5:03 AM | Cellectar Biosciences (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/31/2024 7:00 AM | ADAR1 Partners, LP (Filed by) Cellectar Biosciences (Subject)
| Form SC 13G | |
01/09/2024 5:02 AM | Cellectar Biosciences (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/12/2023 7:04 PM | CARUSO JAMES V (Reporting) Cellectar Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
|
12/12/2023 7:04 PM | Cellectar Biosciences (Issuer) Longcor Jarrod (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/12/2023 7:05 PM | Cellectar Biosciences (Issuer) Shustov Andrei (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/12/2023 7:07 PM | Cellectar Biosciences (Issuer) Kolean Chad J (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/12/2023 7:09 PM | Cellectar Biosciences (Issuer) Lea Darrell Shane (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/07/2023 4:15 PM | Cellectar Biosciences (Subject) LYTTON LAURENCE W (Filed by)
| Form SC 13G | |
12/05/2023 5:01 AM | Cellectar Biosciences (Subject) HIRSCHMAN ORIN (Filed by)
| Form SC 13G | |
11/29/2023 3:31 PM | Cellectar Biosciences (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/13/2023 5:30 AM | Cellectar Biosciences (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
11/02/2023 6:45 AM | Cellectar Biosciences (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/30/2023 11:15 PM | Cellectar Biosciences (Filer)
| Form EFFECT | |
10/27/2023 3:40 PM | Cellectar Biosciences (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/25/2023 3:54 PM | Cellectar Biosciences (Filer)
| Form S-3/A | |
10/05/2023 3:45 PM | Cellectar Biosciences (Filer)
| Form S-3 Registration statement under Securities Act of 1933 | |
10/02/2023 3:40 PM | Cellectar Biosciences (Filer)
| Form DEF 14A | |
09/22/2023 3:40 PM | Cellectar Biosciences (Filer)
| Form PRE 14A | |
09/22/2023 3:30 PM | Cellectar Biosciences (Filer)
| Form D Notice of Exempt Offering of Securities | |
09/08/2023 4:17 PM | Cellectar Biosciences (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/21/2023 3:30 PM | Cellectar Biosciences (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/14/2023 7:45 AM | Cellectar Biosciences (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/14/2023 7:30 AM | Cellectar Biosciences (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
06/29/2023 3:31 PM | Cellectar Biosciences (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/29/2023 5:03 AM | Cellectar Biosciences (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/28/2023 5:27 PM | Cellectar Biosciences (Issuer) Swirsky Douglas J (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/28/2023 5:24 PM | Cellectar Biosciences (Issuer) Chanan-Khan Asher (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/28/2023 5:24 PM | Cellectar Biosciences (Issuer) DRISCOLL FREDERICK W (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/28/2023 5:25 PM | Cellectar Biosciences (Issuer) Loren Stefan (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/28/2023 5:26 PM | Cellectar Biosciences (Issuer) NEIS JOHN (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/20/2023 5:08 AM | Cellectar Biosciences (Filer)
| Form 8-K/A | |
06/20/2023 5:09 AM | Cellectar Biosciences (Filer)
| Form DEFA14A | |
06/14/2023 3:25 PM | Cellectar Biosciences (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/14/2023 3:27 PM | Cellectar Biosciences (Filer)
| Form DEFA14A | |
06/13/2023 3:30 PM | Cellectar Biosciences (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/04/2023 7:45 AM | Cellectar Biosciences (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/04/2023 7:31 AM | Cellectar Biosciences (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
Trump’s “Tax Free” Retirement Strategy (Ad) Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value.
In other words, a dollar back then would buy $17.82 worth of goods in today's money.
If you're planning on retiring any time soon…This poses a real problem. Protect your retirement savings from the inevitable devaluation of the dollar… |